Laura Donovan, APRN
Nurse Practitioner · Omaha, NENPI 1437529880
Payments from drug & device makers
Across 670 payments — averaging $72.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$40K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Johnson & Johnson$984
- Takeda Pharmaceuticals U.S.A., Inc.$905
- Sanofi$354
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 210 | $39,645 |
| AbbVie | 131 | $2,361 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 79 | $1,559 |
| Johnson & Johnson(2 entities) | 66 | $984 |
| Takeda Pharmaceuticals U.S.A., Inc. | 42 | $905 |
| Sanofi | 14 | $354 |
| Madrigal Pharmaceuticals | 19 | $332 |
| Ipsen Biopharmaceuticals, Inc | 7 | $278 |
| Regeneron Healthcare Solutions, Inc. | 13 | $262 |
| Bristol Myers Squibb | 12 | $207 |
| Aimmune Therapeutics, Inc. | 2 | $204 |
| Ironwood Pharmaceuticals, Inc | 10 | $195 |
| Nestle Healthcare Nutrition Inc. | 3 | $191 |
| Ferring Pharmaceuticals Inc. | 5 | $130 |
| Intercept Pharmaceuticals, Inc. | 8 | $128 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Amgen | 1 | $122 |
| Ardelyx, Inc. | 7 | $110 |
| Pfizer | 6 | $104 |
| Phathom Pharmaceuticals, Inc. | 7 | $88 |
| Boehringer Ingelheim | 4 | $88 |
| Merck | 4 | $66 |
| Celltrion USA Inc. | 3 | $59 |
| Novo Nordisk | 3 | $57 |
| QOL Medical, LLC | 3 | $43 |
| Smith+Nephew | 1 | $34 |
| Braintree Laboratories, Inc. | 2 | $32 |
| Ambu Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $22 |
| Exact Sciences | 1 | $19 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Evoke Pharma, Inc. | 1 | $17 |
| UCB, Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
How this compares
$48,795 in reported general payments places this provider in the 95th percentile of 924 nurse practitioner providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Omaha
- Kristen HammesOmaha$899K
- Amy MuchowiczOmaha$78K
- Kari CunninghamOmaha$53K
- Kathleen HealeyOmaha$36K
- Katie RuchOmaha$26K
- Amanda GuggenmosOmaha$23K
- Amy YagerOmaha$15K
- Cara SchiesslerOmaha$14K
- Lindsay OneilOmaha$13K
- Beverly EverittOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.